At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SHPH Shuttle Pharmaceuticals Inc
Trading 12-22 10:58:16 EST
1.84
+0.12
+6.98%
High1.84
Low1.72
Vol13.04K
Open1.74
D1 Closing1.72
Amplitude6.96%
Mkt Cap2.95M
Tradable Cap2.80M
Total Shares1.60M
T/O23.42K
T/O Rate0.86%
Tradable Shares1.52M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
BRIEF-Shuttle Pharmaceuticals Holdings Inc - Timothy Lorber Resigns As CFO Of Shuttle Pharmaceuticals - SEC Filing
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.